Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye
Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the grant of European Patent